Searched for
CURATEQ
Bombay HC backs GSK in Paxil trademark row against Shreya Life SciencesThe Indian subsidiary of the UK-based GSK PLC had urged the court to cancel the mark used by the local company in pharmaceutical and medici...- Aurobindo Pharma arm CuraTeQ gets Health Canada nod for biosimilarAurobindo Pharma announced a significant development today. Its subsidiary, CuraTeQ Biologics, has received a compliance notice from Health...
- Stocks in news: TCS, HCL Tech, DMart, ICICI Lombard, RIL, Lemon Tree HotelsMarkets extended their decline on Friday, mirroring weak global cues and disrupting the Nifty's short-term up move. Several companies like ...
- Aurobindo Pharma’s Dyrupeg faces Health Canada compliance noticeCuraTeQ Biologics, a part of Aurobindo Pharma, has secured a crucial approval from Health Canada for its biosimilar drug Dyrupeg. This medi...
- Aurobindo Pharma shares in focus after European Commission nod for cancer drug DazublysAurobindo Pharma's subsidiary, CuraTeQ Biologics, secured European Commission approval for its trastuzumab biosimilar, Dazublys, indicated ...
- Aurobindo Pharma shares rise 2% after subsidiary CuraTeQ gets UK nod for DyrupegAurobindo Pharma shares: In the March quarter, Aurobindo Pharma posted a consolidated revenue of ₹8,382.1 crore, marking an 11% increase co...
- Stocks in news: Vodafone Idea, Vedanta, Hindalco Industries, Mastek, Aurobindo PharmaMarket witnessed volatility with marginal gains, while Vedanta, Adani Enterprises, and Dalmia Bharat Cement vie for Jaiprakash Associates. ...
- Stocks in news on Budget day: ITC, Sun Pharma, Vishal Mega Mart, Infosys, Hero MotoCorp, HUL, RVNL, IRCTCStock to News on Budget Day Today: So, watch out for ITC, Sun Pharma, Vishal Mega Mart, Infosys, Hero MotoCorp, HUL, RVNL, IRCTC and a slew...
- Aurobindo Pharma shares jump 2% after UK arm secures regulatory approval for cancer drugAurobindo Pharma's stock rose after its subsidiary got approval for a cancer drug. CuraTeQ Biologics received the UK's MHRA approval for Be...
- Stocks in news: RIL, NTPC Green, IndusInd Bank, Zomato, Vedanta, IOCIn today's trade, shares of RIL, NTPC Green, IndusInd Bank, Zomato and Vedanta will be in focus due to various news developments. Zomato sh...
- Stocks in news: Vedanta, Dixon Tech, Bharat Forge, ONGC, RILDixon Technologies and Chinese smartphone maker Vivo are entering into a joint venture that will manufacture smartphones for the smartphone...
- Aurobindo Pharma signs pact with MSD to supply biologicals, to invest Rs.1000 crore on plantAurobindo Pharma's subsidiary, TheraNym Biologics Pvt Ltd, has signed a master service agreement with Merck Sharpe & Dohme Singapore for co...
- Aurobindo Pharma arm extends negotiations deadline with MSD for contract manufacturing operationsAurobindo Pharma extends deadline for CuraTeQ Biologics and Merck Sharp & Dohme Singapore negotiations on contract manufacturing operations...
- Aurobindo Pharma eyes $5-B revenue in 5 yearsAurobindo Pharma has undergone a significant reorganisation, restructuring its operations into three subsidiaries. Eugia Pharma Specialitie...
- Aurobindo Pharma subsidiary enters pact with BioFactura for biosimilar ustekinumabCuraTeQ Biologics, a wholly owned subsidiary of Aurobindo Pharma said it has entered into an exclusive license agreement with the US-based ...
- Stocks in news: Cyient DLM, HDFC Bank, Bajaj Auto, Hindustan ZincSuzlon Energy Ltd on Friday said its board has approved a proposal to raise up to Rs 2,000 crore. The company will explore various financia...
- Stocks in news: LTIMindtree, Mankind Pharma, RBL Bank, Suzlon Energy, Aurobindo PharmaMankind Pharma, a recent entrant to the stock exchanges, has been included to several Nifty indices including Nifty500, Nifty Midcap150, Ni...
- Stocks in news: TCS, HDFC Life, Shree Cement, Aurobindo Pharma, Bank of MaharashtraThe European Medicines Agency’s (EMA) Committee has accepted Aurobindo Pharma subsidiary CuraTeQ Biologics' request to withdraw the applica...
- Stocks in the news: Infosys, Adani Enterprises, Hero Moto, UPL and Auro PharmaIT major Infosys has completed the acquisition of Europe-based life sciences consulting and technology firm BASE life science, which will f...
- Aurobindo Pharma's arm to invest around Rs 300 crore for biologics manufacturing facilitiesThe board of directors of CuraTeQ Biologics Pvt Ltd, at its meeting held on Thursday, approved the expansion of its operations by establish...
Load More
